These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1641821)

  • 1. Production and therapeutic use of a factor XI concentrate from plasma.
    Bolton-Maggs PH; Wensley RT; Kernoff PB; Kasper CK; Winkelman L; Lane RS; Smith JK
    Thromb Haemost; 1992 Mar; 67(3):314-9. PubMed ID: 1641821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of factor XI (FXI) concentrate use in patients with FXI deficiency: a single-centre experience of 19 years.
    Ling G; Kagdi H; Subel B; Chowdary P; Gomez K
    Haemophilia; 2016 May; 22(3):411-8. PubMed ID: 26663472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven®, a factor XI concentrate.
    Santoro C; Goldberg I; Bridey F; Figgie MP; Karila-Israel D; Haviland K; Mackenzie CR; Dimichele DM
    Haemophilia; 2011 Sep; 17(5):777-82. PubMed ID: 21699628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
    Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
    Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.
    Goudemand J; Peynet J; Chambost H; Négrier C; Briquel ME; Claeyssens S; Derlon-Borel A; Guérois C; Caron C; Scherrmann JM; Debray M; Bridey F
    Thromb Haemost; 1998 Dec; 80(6):919-24. PubMed ID: 9869161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.
    Bauduer F; de Raucourt E; Boyer-Neumann C; Trossaert M; Beurrier P; Faradji A; Peynet J; Borg JY; Chamouni P; Chatelanaz C; Henriet C; Bridey F; Goudemand J;
    Haemophilia; 2015 Jul; 21(4):481-9. PubMed ID: 25817556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up.
    Mauser-Bunschoten EP; Posthouwer D; Fischer K; van den Berg HM
    Haemophilia; 2007 Nov; 13(6):697-700. PubMed ID: 17877729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study.
    Bolton-Maggs PH; Patterson DA; Wensley RT; Tuddenham EG
    Thromb Haemost; 1995 Feb; 73(2):194-202. PubMed ID: 7792729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
    Livnat T; Tamarin I; Mor Y; Winckler H; Horowitz Z; Korianski Y; Bar-Zakay B; Seligsohn U; Salomon O
    Thromb Haemost; 2009 Sep; 102(3):487-92. PubMed ID: 19718468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
    Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
    Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate.
    Collins PW; Goldman E; Lilley P; Pasi KJ; Lee CA
    Haemophilia; 1995 Oct; 1(4):227-31. PubMed ID: 27214628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dental surgery in patients with severe factor XI deficiency without plasma replacement.
    Berliner S; Horowitz I; Martinowitz U; Brenner B; Seligsohn U
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):465-8. PubMed ID: 1420822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications for fresh frozen plasma: evaluation of virus inactivating preparations].
    Pindur G; Kiesewetter H; Seyfert UT; Wenzel E
    Beitr Infusionsther; 1993; 31():74-80. PubMed ID: 7693268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of an aneurysmal subarachnoid hemorrhage in a patient with known factor XI deficiency: a case report.
    Siao D; Seetapah A; Ryman A; Guerin V; Mesli A; Maurette P
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):108-11. PubMed ID: 18160615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.
    Goldsmith JC
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital deficiency of factor XI: diagnosis and therapy in surgical patients (author's transl)].
    Robert A; Huguet C; Conard H; Homberg JC; Samama M
    Anesth Analg (Paris); 1980; 37(3-4):187-90. PubMed ID: 7377567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
    Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
    Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.